Vaccine policy and incidence of influenza

Epidemiology

Volumn 21, Issue 2, 2010, Pages 270-271

  Jick, Hershel ^a   Chamberlin, Douglas P ^a   Hagberg, Katrina W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; INCIDENCE; INFLUENZA; LETTER; PRIORITY JOURNAL; SEASONAL VARIATION; UNITED KINGDOM; VACCINATION;

ADULT; AGED; DISEASE OUTBREAKS; HEALTH POLICY; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; SEASONS; YOUNG ADULT;

EID: 77249157966     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181cc95f8     Document Type: Letter

References (8)

1. Fleming DM, Elliot AJ. Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect. 2008;136:866-875.
2. Crofts JP, Joseph CA, Zambon M, Ellis J, Fleming DH, Watson JM. Influenza surveillance in the United Kingdom: October 2002 to May 2003. Communicable Disease Report Supplement, 2003.
3. Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilization associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis. 2000;19:834-942.
4. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23:686-689.
5. Hollowell J. General Practice Research Database (GPRD): scope and quality of data. OPCS. 1994;1-20.
6. Jick H, Chamberlin DP, Hagberg KW. The origin and spread of a mumps epidemic in the United Kingdom, 2003-2006. Epidemiology. 2009;20:656-661
7. Influenza/Respiratory Virus Team, HPA Centre for Infections. HPA National Influenza Season Summary 2007/08. Report for 5 August 2008. http://www.hpa.org.uk/web/HPAwebFile/ HPAweb-C/1217490135145.
8. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancer Infect Dis. 2007;7:658-666.